The meta-analysis demonstrated that a low level of MUC2 expression was associated with lymphatic invasion in patients with CRC (RR, 1.64; 95% CI, 1.26–2.12; P = 0.0002; Figure 3(c)). This evidence concerns the gene MUC2 and colorectal carcinoma.